Champions Oncology Stock Price

0.01 (0.11%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Champions Oncology Inc CSBR NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.01 0.11% 9.42 9.37 9.45 9.45 9.41 13:55:02
Bid Price Ask Price Spread Spread % News
9.41 9.47 0.06 0.63% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
71 3,696 $ 9.42 $ 34,815 70,177 4.02 - 10.89
Last Trade Time Type Quantity Stock Price Currency
13:54:57 3 $ 9.435 USD

Champions Oncology Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 119.89M 12.73M 7.62M $ 32.12M $ -1.69M -0.19 -71.09
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.25k -

more financials information »

Champions Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CSBR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.749.638.619.1821,6450.687.78%
1 Month9.2010.898.059.1839,8210.222.39%
3 Months9.1610.898.059.2655,5860.262.84%
6 Months6.9910.894.028.4340,0442.4334.76%
1 Year5.6710.894.027.5542,5313.7566.14%
3 Years3.1517.902.7759.2565,7606.27199.05%
5 Years4.5317.901.117.2259,5974.89107.95%

Champions Oncology Description

Champions Oncology Inc is a US-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.

Your Recent History
Champions ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.